Improving lives by creating medicines unlocked by science.
MJ Wooly Biotech isolates molecules, formulates them to treat specific medical conditions, then packages this into novel drug delivery systems. We have proven this concept by developing our own patent pending drug delivery system.
Watch below for a demonstration of our latest patent pending technology. Nano-particle CBD in powder form, seamlessly mixing into water.
Examples of technology applications...
MJ Wooly Biotech, is targeting unique pharmaceutical/nutraceutical opportunities to leverage our team's R&D experience. Many of the innovations are directly applicable to the cannabis industry. This nascent industry, will create an entirely new category of pharmaceuticals that have the potential to treat illness ranging from chronic pain to neurodegenerative diseases.
MJ Wooly identifies enigmatic cannabinoids and elucidate their ability to treat specific health conditions and improve wellness. MJ Wooly creates core technologies for the synthesis and purification of rare cannabinoids.
There are many challenges for cannabinoid drug delivery: it is degraded by our digestive system, the molecules have poor absorption by our bodies and the effects are severely delayed. MJ Wooly Biotech has overcome these obstacles by inventing a patent pending drug delivery system. This delivery vehicle is robust and can be loaded with a wide variety of drug compounds. The purpose is to make cannabis medicines more consistent, safe and effective.
MJ Wooly’s strategy is to fill in the technological gap that currently exists, by creating innovations founded on sound scientific principles and good manufacturing practices. Our company creates valuable assets through a diverse IP portfolio revolving around cannabinoid medicine.